Remember me
Objectives
The study aims to compare the diagnostic accuracy of MRI and CT scan features in differentiating medulloblastoma from ependymoma, two similar pediatric brain tumors.
Materials & Methods
This retrospective cross-sectional study was conducted on all pediatric patients with posterior fossa tumors admitted to teaching hospitals affiliated with Isfahan University of Medical Sciences from 2017 to 2022. Forty-three patients with posterior fossa tumors were identified, and seven patients were excluded due to diagnoses other than medulloblastoma or ependymoma. Tumor morphology on MRI, tumor density on CT scan, and apparent diffusion coefficient (ADC) values were assessed to differentiate medulloblastoma from ependymoma.
Results
Histopathologic diagnosis was medulloblastoma in 21 patients (60%) and ependymoma in 14 patients (40%). Mean ADC values in medulloblastoma and ependymoma cases were 0.67±0.19 (range= 0.50-1.25) and 1.22±0.29 (range=0.67-1.72), showing a significant statistical difference between the two groups (p-value=0.000). The ADC cut-off point of 0.9825 was associated with 90% sensitivity and 92.9% specificity for differentiation of ependymoma from medulloblastoma.
Conclusion
While tumor morphology on MRI and other studied parameters are unreliable for differentiating medulloblastoma and ependymoma, ADC values may provide a potential diagnostic tool. Further studies are needed to confirm the utility of DWI and other advanced MRI techniques in differentiating these tumors
1. Baldwin RT, Preston-Martin S. Epidemiology of brain tumors in childhood-a review. Toxicol Appl Pharmacol 2004; 1992: 118–131.
2. Pollack IF. Brain tumors in children. N Engl J Med 1994; 331: 1500–1507.
3. Poretti A, Meoded A, Huisman TA. Neuroimaging of pediatric posterior fossa tumors including review of the literature. J Magn Reson Imaging. 2012 Jan;35(1):32-47. doi: 10.1002/jmri.22722. Epub 2011 Oct 11. PMID: 21989968.
4. Dhall G. Medulloblastoma. J Child Neurol 2009; 24: 1418–1430.
5. Davis FG, McCarthy BJ. Epidemiology of brain tumors. Curr Opin Neurol 2000; 13: 635–640.
6. Villano JL, Parker CK, Dolecek TA. Descriptive epidemiology of ependymal tumours in the United States. Br J Cancer. 2013 Jun 11;108(11):2367-71. doi: 10.1038/bjc.2013.221. Epub 2013 May 9. PMID: 23660944; PMCID: PMC3681017.
7. Dong J, Li L, Liang S, Zhao S, Zhang B, Meng Y, Zhang Y, Li S. Differentiation Between Ependymoma and Medulloblastoma in Children with Radiomics Approach. Acad Radiol. 2021 Mar;28(3):318-327. doi: 10.1016/j.acra.2020.02.012. Epub 2020 Mar 26. PMID: 32222329.
8. Albright AL. Pediatric brain tumors. CA 1993; 43:272–288.
9. Kobayashi K, Ando K, Kato F, Kanemura T, Imagama S, Sato K, et al. MRI characteristics of
spinal ependymoma in WHO grade II: a review of 59 cases. Spine. 2018;43(9):E525-E30.
10. Kotani T, Okawa A, Akazawa T, Sakuma T. Mobile ependymoma diagnosed with cine MRI.
Case Reports. 2014;2014:bcr2013202984
11. Xianwang L, Lei H, Hong L, Juan D, Shenglin L, Caiqiang X, et al. Apparent Diffusion Coefficient to Evaluate Adult Intracranial Ependymomas: Relationship to Ki‐67 Proliferation Index. Journal of Neuroimaging. 2021;31(1):132-6.
12. Taheri H, Tavakoli MB. Measurement of Apparent Diffusion Coefficient (ADC) Values of Ependymoma and Medulloblastoma Tumors: a Patient-based Study. J Biomed Phys Eng. 2021 Feb 1;11(1):39-46. doi: 10.31661/jbpe.v0i0.889. PMID: 33564638; PMCID: PMC7859369.
13. Wang, T., Wu, X., Cui, Y. et al. Role of apparent diffusion coefficients with diffusion-weighted magnetic resonance imaging in differentiating between benign and malignant bone tumors. World J Surg Onc 12, 365 (2014). https://doi.org/10.1186/1477-7819-12-365
14. Dury RJ, Lourdusamy A, Macarthur DC, Peet AC, Auer DP, Grundy RG, Dineen RA. Meta-Analysis of Apparent Diffusion Coefficient in Pediatric Medulloblastoma, Ependymoma, and Pilocytic Astrocytoma. J Magn Reson Imaging. 2022 Jul;56(1):147-157. doi:10.1002/jmri.28007. Epub 2021 Nov 29. PMID: 34842328.
15. Mohamed, F. F., Azeem Ismail, A. A., Hasan, D. I., & Essa, W. E. (2013). The role of apparent diffusion coefficient (ADC) value in the differentiation between the most common pediatric posterior fossa tumors. The Egyptian Journal of Radiology and Nuclear Medicine, 44(2), 349-355. doi:https://doi.org/10.1016/j.ejrnm.2012.12.011
16. Rumboldt Z, Camacho D L, Lake D, Welsh C T, Castillo M. Apparent diffusion coefficients for differentiation of cerebellar tumors in children. AJNR Am J Neuroradiol. 2006;27:1362–9.
17. Esa, M.M.M., Mashaly, E.M., El-Sawaf, Y.F. et al. Diagnostic accuracy of apparent diffusion coefficient ratio in distinguishing common pediatric CNS posterior fossa tumors. Egypt J Radiol Nucl Med 51, 76 (2020). https://doi.org/10.1186/s43055-020-00194-2
18. Novak, J., Zarinabad, N., Rose, H. et al. Classification of paediatric brain tumours by diffusion weighted imaging and machine learning. Sci Rep 11, 2987 (2021).
19. Duc NM. The effect of semi-quantitative T1-perfusion parameters for the differentiation
between pediatric medulloblastoma and ependymoma. Egyptian Journal of Radiology and Nuclear Medicine. 2020;51(1):1-6.
20. Duc NM, Huy HQ, Nadarajan C, Keserci B. The role of predictive model based on quantitative basic magnetic resonance imaging in differentiating medulloblastoma from ependymoma. Anticancer research. 2020;40(5):2975-80.
21. Eran A, Ozturk A, Aygun N, Izbudak I. Medulloblastoma: atypical CT and MRI findings in
children. Pediatric radiology. 2010;40(7):1254-62.
Comments (0)